Director, Competitive Intelligence

Overview
At Alnylam Pharmaceuticals, we are pioneering the future of RNAi therapeutics. We seek a dynamic and strategic Director of Competitive Intelligence to drive critical insights that inform decision-making across our clinical and commercial programs.

This role is pivotal to shaping the strategic direction of our portfolio by delivering synthesized, forward-looking intelligence on the evolving competitive landscape. Partnering closely with R&D, Medical Affairs, and Commercial colleagues, you will ensure that competitive insights are integrated, actionable, and aligned with business priorities.

The ideal candidate brings exceptional scientific depth, business acumen, and executive presence, paired with a collaborative mindset and the ability to influence at all levels of the organization.

This role reports to the Director, Insights & Analytics and is a key contributor within the Customer Experience & Innovation (CX&I) team.

Key Responsibilities

• Competitive Monitoring & Analysis: Continuously monitor the evolving competitive landscape, interpreting complex competitor activities and distilling findings into high-value, strategically relevant insights that shape decision-making.
• Synthesis & Strategic Implication: Integrate diverse data streams into coherent, forward-looking narratives that go beyond reporting - delivering the "so what" through clear articulation of risks, opportunities, and recommended strategic actions.
• Therapeutic Area Breadth: Rapidly develop expertise across multiple therapeutic areas to support an expanding and dynamic pipeline, ensuring insights remain comprehensive, timely, and impactful.
• Cross-functional Collaboration: Serve as a strategic integrator across R&D, Medical Affairs, and Commercial teams, connecting inputs and perspectives to build unified, enterprise-aligned competitive intelligence outputs.
• Scientific Credibility: Leverage advanced scientific knowledge to engage credibly with scientific and clinical teams, enabling nuanced interpretation of competitor data and implications for Alnylam's programs.
• Executive Communication: Craft and deliver succinct, high-impact presentations tailored to senior leadership audiences, driving alignment, action, and strategic clarity at the highest levels of the organization.
• Vendor Management: Lead partnerships with external competitive intelligence vendors, ensuring deliverables meet the highest standards of strategic relevance, quality, and timeliness; oversee project scopes, execution, and delivery.
• Ad Hoc Support: Act as a responsive and strategic partner to leadership by delivering clear, high-quality, time-sensitive competitive analyses and recommendations as business needs evolve.
• Process Innovation: Continuously enhance competitive intelligence processes, tools, and knowledge-sharing frameworks to accelerate insight generation, scale impact across the organization, and elevate the strategic value of CI.

Qualifications

• Advanced degree in a life sciences discipline (PhD, PharmD, or MS required).

• Minimum of 10+ years of progressive experience in competitive intelligence, strategy, new product planning, consulting, or related fields within the biopharma industry.
• Experience supporting both clinical development and commercial organizations preferred.
• Experience in global, matrixed organizations preferred.
• Demonstrated success in matrixed environments and influencing without direct authority.
• Effective collaborator with a track record of driving alignment across functional boundaries.
• Strong scientific acumen with the ability to synthesize clinical, scientific, and market data into actionable business insights.
• Proven ability to develop executive-level communications and strategic recommendations.
• Experience managing external vendors and CI-related projects.
• Proficiency in CI tools, databases, and Microsoft Office Suite (especially PowerPoint and Excel).
• Highly motivated, adaptable, intellectually curious, and results-driven.

Willingness to travel up to 5-10% to Congresses, home office or internal cross-functional engagements.

Leadership Capabilities & Core Competencies

• Knowledge: Recognized as a functional expert with advanced understanding of patient behavior, market dynamics, and therapeutic landscapes. Applies in-depth expertise to guide internal teams and inform strategic direction through innovative, forward-looking insights.
• Business Acumen: Anticipates and interprets evolving industry trends and competitive forces. Integrates external dynamics with internal business priorities to guide product strategy, portfolio decisions, and enterprise-level performance.
• Leadership: Leads initiatives with significant complexity and impact. Develops and executes strategy across cross-functional teams; consults with senior leaders and mentors peers to enhance organizational capabilities and strategic thinking.
• Decision Making: Uses advanced analytical judgment to proactively identify solutions to complex and ambiguous business challenges. Develops novel approaches that influence brand direction and drive strategic clarity; maintains an enterprise mindset in high-stakes decisions.
• Impact & Accountability: Influences strategic direction and resource allocation by ensuring competitive insights directly inform brand strategy, messaging, access, and patient engagement. Holds self and collaborators accountable for high-quality, insight-driven outcomes.
• Influence: Communicates complex recommendations clearly and persuasively, often to senior stakeholders. Anticipates challenges, addresses objections, and effectively negotiates across functions to align on strategic priorities and decisions.

About Alnylam:Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by "interfering" with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality.

Our culture:Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we've been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as the #1 Large Employer by Boston Globe Top Places to Work in 2023 for the third consecutive year, one of Science Magazine's Top Biopharma Employers, one of America's Most Responsible Companies for 2024 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK - among others.

At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients. Qualified applicants will receive consideration for employment without regard to their race, color, religion, age, sex, sexual orientation, gender identity or expression, national origin, ethnicity, marital status, protected veteran status, disability, or any other characteristics prohibited by law.